These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2259448)

  • 1. Effect of a synthetic norepinephrine precursor, L-threo-3,4- dihydroxyphenylserine on the total norepinephrine concentration in the cerebrospinal fluid of parkinsonian patients.
    Tohgi H; Abe T; Takahashi S; Takahashi J; Ueno M; Nozaki Y
    Neurosci Lett; 1990 Aug; 116(1-2):194-7. PubMed ID: 2259448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients.
    Tohgi H; Abe T; Takahashi S
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):27-34. PubMed ID: 8439390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M; Ogawa N; Ujike H
    J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantial renal conversion of L-threo-3,4-dihydroxyphenylserine (droxidopa) to norepinephrine in patients with neurogenic orthostatic hypotension.
    Lamotte G; Holmes C; Sullivan P; Goldstein DS
    Clin Auton Res; 2019 Feb; 29(1):113-117. PubMed ID: 30229336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in freezing phenomenon of Parkinson's disease after DL-threo-3, 4-dihydroxyphenylserine.
    Ogawa N; Kuroda H; Yamamoto M; Nukina I; Ota Z
    Acta Med Okayama; 1984 Jun; 38(3):301-4. PubMed ID: 6431755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of parkinsonism with L-threo-3,4-dihydroxyphenylserine: a pharmacokinetic study.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S; Hayashi A; Kondo T; Narabayashi H
    Neurology; 1984 Nov; 34(11):1446-50. PubMed ID: 6436731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-threo-3, 4-dihydroxyphenylserine treatment of Parkinson's disease.
    Ogawa N; Yamamoto M; Takayama H
    J Med; 1985; 16(5-6):525-34. PubMed ID: 3938472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S
    Life Sci; 1985 Feb; 36(5):435-42. PubMed ID: 3918223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of L-threo-DOPS, a norepinephrine precursor amino acid].
    Katsube J; Narabayashi H; Hayashi A; Tanaka C; Suzuki T
    Yakugaku Zasshi; 1994 Nov; 114(11):823-46. PubMed ID: 7853146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective treatment of pure akinesia with L-threo-3,4-dihydroxyphenylserine (DOPS): report of a case, with pharmacological considerations.
    Yamamoto M; Ujike H; Ogawa N
    Clin Neuropharmacol; 1985; 8(4):334-42. PubMed ID: 2416437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine metabolism during additional administration of DL-threo-3,4-dihydroxyphenylserine to patients with Parkinson's disease.
    Teelken AW; van den Berg GA; Muskiet FA; Staal-Schreinemachers AL; Wolthers BG; Lakke JP
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):177-88. PubMed ID: 2476157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
    Ishikawa Y; Kato Y; Murakami Y; Inoue T; Koshiyama H; Imura H
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):197-200. PubMed ID: 3101067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
    Birkmayer W; Birkmayer G; Lechner H; Riederer P
    J Neural Transm; 1983; 58(3-4):305-13. PubMed ID: 6420517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new metabolic pathway of L-threo-3,4-dihydroxyphenylserine, a precursor amino acid of norepinephrine, in the brain. Studies by in vivo microdialysis.
    Maruyama W; Nakahara D; Naoi M
    J Neural Transm Park Dis Dement Sect; 1994; 7(1):21-33. PubMed ID: 8579767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS.
    Goldstein DS; Holmes C; Sewell L; Pechnik S; Kopin IJ
    J Clin Pharmacol; 2011 Jan; 51(1):66-74. PubMed ID: 20220040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-threo-3,4-dihydroxyphenylserine treatment for gait apraxia in parkinsonian patients.
    Yoshida M; Noguchi S; Kuramoto S
    Kurume Med J; 1989; 36(2):67-74. PubMed ID: 2511378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-threo-3,4-dihydroxyphenylserine on regional cerebral blood flow in patients with Parkinson's disease.
    Ujike H; Yamamoto M
    J Neurol Sci; 1988 Jan; 83(1):75-80. PubMed ID: 3126272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DL-threo-3,4-dihydroxyphenylserine for freezing symptom in parkinsonism.
    Narabayashi H; Kondo T; Nagatsu T; Hayashi A; Suzuki T
    Adv Neurol; 1984; 40():497-502. PubMed ID: 6421112
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacokinetics of the norepinephrine precursor L-threo-DOPS in primary chronic autonomic failure.
    Goldstein DS; Holmes C; Kaufmann H; Freeman R
    Clin Auton Res; 2004 Dec; 14(6):363-8. PubMed ID: 15666063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.